Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 4
1963 3
1965 3
1968 1
1969 3
1970 2
1971 4
1972 1
1973 2
1974 2
1975 1
1977 2
1978 2
1980 4
1981 1
1985 3
1986 5
1987 7
1988 7
1989 7
1990 15
1991 20
1992 20
1993 15
1994 32
1995 37
1996 27
1997 32
1998 48
1999 44
2000 51
2001 56
2002 41
2003 37
2004 39
2005 49
2006 85
2007 126
2008 134
2009 135
2010 152
2011 147
2012 184
2013 224
2014 223
2015 241
2016 220
2017 232
2018 262
2019 290
2020 130
Text availability
Article attribute
Article type
Publication date

Search Results

3,044 results
Results by year
Filters applied: . Clear all
Page 1
The N-Degron Pathway Mediates ER-phagy.
Ji CH, Kim HY, Heo AJ, Lee SH, Lee MJ, Kim SB, Srinivasrao G, Mun SR, Cha-Molstad H, Ciechanover A, Choi CY, Lee HG, Kim BY, Kwon YT. Ji CH, et al. Among authors: Lee SH, Lee MJ, Lee HG. Mol Cell. 2019 Sep 5;75(5):1058-1072.e9. doi: 10.1016/j.molcel.2019.06.028. Epub 2019 Jul 30. Mol Cell. 2019. PMID: 31375263
eDoctor: machine learning and the future of medicine.
Handelman GS, Kok HK, Chandra RV, Razavi AH, Lee MJ, Asadi H. Handelman GS, et al. Among authors: Lee MJ. J Intern Med. 2018 Dec;284(6):603-619. doi: 10.1111/joim.12822. Epub 2018 Sep 3. J Intern Med. 2018. PMID: 30102808 Review.
Imaging features of Benign Perianal lesions.
O'Neill DC, Murray TE, Thornton E, Burke J, Dunne R, Lee MJ, Morrin MM. O'Neill DC, et al. Among authors: Lee MJ. J Med Imaging Radiat Oncol. 2019 Oct;63(5):617-623. doi: 10.1111/1754-9485.12934. Epub 2019 Aug 1. J Med Imaging Radiat Oncol. 2019. PMID: 31368659 Review.
Quantitative Imaging in Pediatric Hepatobiliary Disease.
Yoon H, Shin HJ, Kim MJ, Lee MJ. Yoon H, et al. Among authors: Lee MJ. Korean J Radiol. 2019 Sep;20(9):1342-1357. doi: 10.3348/kjr.2019.0002. Korean J Radiol. 2019. PMID: 31464113 Free PMC article. Review.
A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses.
Zimmer AS, Nichols E, Cimino-Mathews A, Peer C, Cao L, Lee MJ, Kohn EC, Annunziata CM, Lipkowitz S, Trepel JB, Sharma R, Mikkilineni L, Gatti-Mays M, Figg WD, Houston ND, Lee JM. Zimmer AS, et al. Among authors: Lee MJ, Lee JM. J Immunother Cancer. 2019 Jul 25;7(1):197. doi: 10.1186/s40425-019-0680-3. J Immunother Cancer. 2019. PMID: 31345267 Free PMC article.
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations.
Karzai F, VanderWeele D, Madan RA, Owens H, Cordes LM, Hankin A, Couvillon A, Nichols E, Bilusic M, Beshiri ML, Kelly K, Krishnasamy V, Lee S, Lee MJ, Yuno A, Trepel JB, Merino MJ, Dittamore R, Marté J, Donahue RN, Schlom J, Killian KJ, Meltzer PS, Steinberg SM, Gulley JL, Lee JM, Dahut WL. Karzai F, et al. Among authors: Lee S, Lee MJ, Lee JM. J Immunother Cancer. 2018 Dec 4;6(1):141. doi: 10.1186/s40425-018-0463-2. J Immunother Cancer. 2018. PMID: 30514390 Free PMC article.
The Skin and Intestinal Microbiota and Their Specific Innate Immune Systems.
Coates M, Lee MJ, Norton D, MacLeod AS. Coates M, et al. Among authors: Lee MJ. Front Immunol. 2019 Dec 17;10:2950. doi: 10.3389/fimmu.2019.02950. eCollection 2019. Front Immunol. 2019. PMID: 31921196 Free PMC article. Review.
LIN28A loss of function is associated with Parkinson's disease pathogenesis.
Chang MY, Oh B, Choi JE, Sulistio YA, Woo HJ, Jo A, Kim J, Kim EH, Kim SW, Hwang J, Park J, Song JJ, Kwon OC, Henry Kim H, Kim YH, Ko JY, Heo JY, Lee MJ, Lee M, Choi M, Chung SJ, Lee HS, Lee SH. Chang MY, et al. Among authors: Lee MJ, Lee M, Lee HS, Lee SH. EMBO J. 2019 Dec 16;38(24):e101196. doi: 10.15252/embj.2018101196. Epub 2019 Nov 21. EMBO J. 2019. PMID: 31750563
3,044 results
Jump to page
Feedback